advertisement
Eight-year-old Aditi Shankar has now become the first person in the UK to undergo a breakthrough transplant without the need for lifelong immunosuppressant drugs. How? Her team of doctors reprogrammed her immune system.
Why is this such a big deal for the Indian-origin girl and otherwise? How did her doctors pull it off?
According to her father, Uday Shankar, Aditi had been on dialysis for the past three years.
Due to severe irreversible kidney failure, she required a kidney transplant. However, the risks were high as she had been grappling with a rare genetic condition that affected her immune system.
Aditi's doctors at Great Ormond Street Hospital, London, figured that they could reduce the risk of rejection if they could reprogram her immune system to be the same as her donor kidney.
Aditi had received her mother's bone marrow 6 months before the transplant for and immune condition.
This allowed her immune system to become a match for the new kidney that was also donated by her mother – reducing the problems associated with rejection as much as possible.
This is the first time a kidney transplant like this has been successfully done in the UK where the patient wouldn't need life-long immunosuppressant drugs.
The transplant on Friday, 23 September, was a success, and Aditi's new kidney is able to work without the continued need for immunosuppressant drugs.
According to her parents, Aditi is already doing better.
"The past three years she has been restricted with a Hickman line (an intravenous tube which delivers medication, nutrition and takes blood samples directly from a vein)...she is now starting swimming lessons," he shared.
According to the specialists involved, it is hoped that the success of Aditi's transplant will lead to further investigations into how a bone marrow transplant from the same living organ donor could be used to treat children and adults with kidney failure and other serious conditions.
However, the experts added that in the near future, this will only be for seriously ill patients as a last-resort option, as the risks associated with a double transplant are greater than that of a regular kidney transplant.
(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)
Published: undefined